|
|||||
|
|
Bleeding risk of apixaban,dabigatran, and low-dose rivaroxaban compared with warfarin in Japanese patients with non-valvular atrial fibrillation: a propensity matched analysis of administrative claims data |
|
| Authors: | Shun Kohsaka Tatsunori Murata Naoko Izumi Feng Wang Yasuo Terayama |
| Affiliation: | 1. Department of Cardiology, Keio University School of Medicine, Tokyo, Japan;2. Crecon Medical Assessment Inc., Tokyo, Japan;3. Pfizer Japan Inc., Tokyo, Japan;4. Bristol-Myers Squibb Co., NY, USA;5. Department of Gerontology, School of Medicine, Iwate Medical University, Iwate, Japan |
| Abstract: | |
| Keywords: | Bleeding novel oral anticoagulants nonvalvular atrial filtration apixaban dabigatran rivaroxaban warfarin |